News | Wearables | May 08, 2020

Necklace Monitors ECG and Detects Abnormal Heart Rhythms

Necklace Patient Monitor Detects Abnormal Heart Rhythm. An necklace has been developed that detects abnormal heart rhythm will be showcased for the first time on EHRA Essentials 4 You, a scientific platform of the European Society of Cardiology (ESC). This wearable necklace ECG monitor provides a new and easy method for detecting an abnormal heart rhythm called atrial fibrillation and is accurate, according to a new study from the University of Eastern Finland.

This wearable necklace ECG monitor provides a new and easy method for detecting an abnormal heart rhythm called atrial fibrillation and is accurate, according to a new study from the University of Eastern Finland.


May 2020 — An necklace has been developed that detects abnormal heart rhythm will be showcased for the first time on EHRA Essentials 4 You, a scientific platform of the European Society of Cardiology (ESC).

"The wearable necklace-ECG (electrocardiogram) provides a new and easy method for detecting an abnormal heart rhythm called atrial fibrillation, which is a fast-growing public health problem," said study author Elmeri Santala, a medical student at the University of Eastern Finland.

One of the major causes of stroke is unrecognized and untreated atrial fibrillation. Approximately 25 percent of all strokes are caused by atrial fibrillation (AF). While it is the most common heart rhythm disturbance, atrial fibrillation is often symptomless and intermittent, making its detection and diagnosis challenging. Innovative methods for detection are therefore needed.

This study examined the diagnostic accuracy of an ECG worn around the neck. A single-lead ECG is embedded into the pendant.

To measure their heart rhythm, users start an application on their smartphone then place the necklace pendant between the palms of their hands or between the palm and the chest for 30 seconds. Data are automatically sent to a cloud service and analyzed for atrial fibrillation using artificial intelligence (AI). Within a few seconds, the smartphone application displays the results of the analysis. An ECG report is also generated for physicians to confirm the diagnosis.

The study enrolled 145 adults who used the necklace to measure their own heart rhythm. Participants simultaneously underwent a three-lead ECG recording as a "gold standard" comparison.

Two cardiologists analyzed all ECG readings without knowing the initial rhythm (i.e. they were blinded to the 3-lead ECG recordings and initial 12-lead ECG). Automated AI analysis of the necklace ECG was also performed.

The necklace produced ECG recordings with excellent quality to detect and diagnose atrial fibrillation. Atrial fibrillation diagnoses made by standard ECG measurement were also picked up by the necklace device with high accuracy, both the automated AI analysis and interpretation of the ECG report by a cardiologist.

"The necklace ECG is simple to use and allows repetitive self-monitoring of heart rhythm, thereby improving the likelihood of detecting atrial fibrillation," Santala said. "The ESC recommends screening for atrial fibrillation in people over 65 years of age and in those at high risk of stroke;[1] automated analysis by the necklace ECG is well suited for this purpose. Diagnosis of atrial fibrillation should always be confirmed by a physician using the ECG report."

 

References:

1. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893-2962. doi:10.1093/eurheartj/ehw210.
 


Related Content

News | Atrial Fibrillation

May 26, 2023 — Atrial fibrillation, or AFib , is the most common heart rhythm problem, affecting millions of Americans ...

Home May 26, 2023
Home
News | Atrial Fibrillation

May 18, 2023 — Vektor Medical, pioneers of technology to accurately map arrhythmias using only 12-lead ECG data ...

Home May 18, 2023
Home
News | Atrial Fibrillation

May 17, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmiatreatment and part of Johnson & Johnson ...

Home May 17, 2023
Home
News | Atrial Fibrillation

May 8, 2023 — An innovative three-step ablation approach including ethanol infusion of the vein of Marshall improves ...

Home May 08, 2023
Home
News | Atrial Fibrillation

April 25, 2023 — A score based on four readily available clinical and imaging parameters identifies the heart failure ...

Home April 25, 2023
Home
News | Atrial Fibrillation

April 20, 2023 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias ...

Home April 20, 2023
Home
News | Atrial Fibrillation

April 18, 2023 — Medtronic today announced the 12-month findings that supported the Affera Mapping and Ablation System ...

Home April 18, 2023
Home
News | Atrial Fibrillation

April 6, 2023 — Atrial fibrillation (AFib) not only causes shortness of breath and palpitations but puts patients at ...

Home April 06, 2023
Home
Feature | Atrial Fibrillation

According to our latest study on "Atrial Fibrillation Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by ...

Home April 04, 2023
Home
News | Atrial Fibrillation

March 30, 2023 —Vektor Medical has announced that use of its vMap arrhythmia mapping system during complex atrial ...

Home March 30, 2023
Home
Subscribe Now